NZ598012A - Processes for the preparation of 1,2,4-oxadiazole benzoic acids - Google Patents

Processes for the preparation of 1,2,4-oxadiazole benzoic acids

Info

Publication number
NZ598012A
NZ598012A NZ598012A NZ59801207A NZ598012A NZ 598012 A NZ598012 A NZ 598012A NZ 598012 A NZ598012 A NZ 598012A NZ 59801207 A NZ59801207 A NZ 59801207A NZ 598012 A NZ598012 A NZ 598012A
Authority
NZ
New Zealand
Prior art keywords
processes
preparation
formula
benzoic acids
oxadiazole benzoic
Prior art date
Application number
NZ598012A
Other languages
English (en)
Inventor
Neil G Almstead
Original Assignee
Ptc Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ptc Therapeutics Inc filed Critical Ptc Therapeutics Inc
Publication of NZ598012A publication Critical patent/NZ598012A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ598012A 2006-09-08 2007-09-06 Processes for the preparation of 1,2,4-oxadiazole benzoic acids NZ598012A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84359506P 2006-09-08 2006-09-08
NZ575511A NZ575511A (en) 2006-09-08 2007-09-06 Processes for the preparation of 1,2,4-oxadiazole benzoic acids

Publications (1)

Publication Number Publication Date
NZ598012A true NZ598012A (en) 2013-08-30

Family

ID=38935880

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ598012A NZ598012A (en) 2006-09-08 2007-09-06 Processes for the preparation of 1,2,4-oxadiazole benzoic acids
NZ575511A NZ575511A (en) 2006-09-08 2007-09-06 Processes for the preparation of 1,2,4-oxadiazole benzoic acids

Family Applications After (1)

Application Number Title Priority Date Filing Date
NZ575511A NZ575511A (en) 2006-09-08 2007-09-06 Processes for the preparation of 1,2,4-oxadiazole benzoic acids

Country Status (24)

Country Link
US (2) US7678922B2 (enExample)
EP (1) EP2059513B1 (enExample)
JP (2) JP5955494B2 (enExample)
KR (1) KR101466368B1 (enExample)
CN (1) CN101535284B (enExample)
AR (3) AR062715A1 (enExample)
AU (1) AU2007292915B2 (enExample)
BR (1) BRPI0716996B8 (enExample)
CA (2) CA2662749C (enExample)
CL (1) CL2007002606A1 (enExample)
DK (1) DK2059513T3 (enExample)
ES (1) ES2404348T3 (enExample)
IL (1) IL197445A (enExample)
MX (1) MX2009002439A (enExample)
MY (1) MY148598A (enExample)
NZ (2) NZ598012A (enExample)
PE (2) PE20080771A1 (enExample)
PL (1) PL2059513T3 (enExample)
PT (1) PT2059513E (enExample)
RU (1) RU2495030C2 (enExample)
TW (1) TWI482761B (enExample)
UA (1) UA99265C2 (enExample)
WO (1) WO2008030570A1 (enExample)
ZA (1) ZA200901782B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2910551T3 (pl) 2003-04-11 2017-09-29 Ptc Therapeutics, Inc. Związki kwasu 1,2,4-oksadiazolobenzoesowego i ich zastosowanie do supresji mutacji nonsensownych i leczenia choroby
PT2402002T (pt) 2005-04-08 2018-10-08 Ptc Therapeutics Inc Composições de 1,2,4-oxadiazole oralmente activo para terapia de supressão de mutações nonsense
CA2647903C (en) 2006-03-30 2016-12-13 Ptc Therapeutics, Inc. Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
WO2008030570A1 (en) * 2006-09-08 2008-03-13 Ptc Therapeutics, Inc. Processes for the preparation of 1,2,4-oxadiazole benzoic acids
EP2068871B1 (en) 2006-09-25 2013-12-25 PTC Therapeutics, Inc. Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and the use for nonsense suppression
SI2076501T1 (sl) * 2006-09-25 2016-05-31 Ptc Therapeutics, Inc. Kristalinične oblike 3-(5-(2-florofenil)-1,2,4) oksadiazol-3-il)-benzojske kisline
ES2538359T3 (es) 2006-10-12 2015-06-19 Ptc Therapeutics, Inc. Métodos para administrar un 1,2,4-oxadiazol activo por vía oral para terapia de supresión de mutación sin sentido
CN101714009A (zh) * 2009-05-14 2010-05-26 翁印嵩 集成通用电话功能的计算机
ES2610362T3 (es) 2011-01-25 2017-04-27 Viviabiotech, S.L. Derivados de 1,2,4-oxadiazol como fármacos moduladores del receptor para el péptido glp-1
UA114915C2 (uk) 2012-07-02 2017-08-28 Монсанто Текнолоджи Ллс Спосіб одержання 3,5-дизаміщених 1,2,4-оксадіазолів (варіанти)
TWI695717B (zh) 2014-03-06 2020-06-11 美商 Ptc 治療公司 １,２,４-二唑苯甲酸之鹽及醫藥組合物
CN105461650B (zh) * 2014-09-12 2018-04-13 杭州普晒医药科技有限公司 一种噁二唑化合物的溶剂化物及其制备方法
CN106316885B (zh) * 2015-07-03 2019-02-12 普济生物科技（台州）有限公司 一种3-[5-(2-氟苯基)-1,2,4-噁二唑-3-基]苯甲酸的制备方法
MX2018005361A (es) 2015-10-30 2018-06-07 Ptc Therapeutics Inc Metodos para tratar epilepsia.
TW201808922A (zh) 2016-06-20 2018-03-16 台灣神隆股份有限公司 製備阿塔魯仁及其中間體的方法
US12268669B2 (en) 2018-12-20 2025-04-08 Pfizer Inc. Pharmaceutical compositions and methods comprising a combination of a benzoxazole transthyretin stabilizer and an additional therapeutic agent
EA202192767A1 (ru) 2019-04-10 2021-12-29 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Способ лечения опосредуемой нонсенс-мутацией мышечной дистрофии дюшенна у педиатрических пациентов
WO2022112919A1 (en) 2020-11-25 2022-06-02 Pfizer Inc. (aza)benzothiazolyl substituted pyrazole compounds
CN113045510B (zh) * 2021-03-31 2022-05-27 北京大学生命科学华东产业研究院 一种阿塔鲁伦的制备方法
CN114920667B (zh) * 2022-06-30 2024-06-21 湖南大学 一种阿塔鲁伦酯的电化学制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2801509A1 (de) * 1978-01-12 1979-07-19 Schering Ag 1,2,4-oxadiazolderivate, verfahren zur herstellung dieser verbindungen sowie diese enthaltende selektive herbizide mittel
DE3905242A1 (de) * 1989-02-21 1990-08-23 Basf Ag Verfahren zur herstellung von phenyloxdiazolylanilinen
NZ234760A (en) * 1989-08-18 1991-09-25 Sterling Drug Inc Antiviral oxazole compounds and compositions
DE4425794A1 (de) * 1994-07-21 1996-01-25 Basf Ag Nitrofarbstoffe
US6660753B2 (en) * 1999-08-19 2003-12-09 Nps Pharmaceuticals, Inc. Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
CA2449544A1 (en) * 2001-06-08 2002-12-19 Cytovia, Inc. Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
MY151199A (en) * 2001-11-02 2014-04-30 Rigel Pharmaceuticals Inc Substituted diphenyl heterocycles useful for treating hcv infection
US20040132726A1 (en) * 2002-08-09 2004-07-08 Astrazeneca Ab And Nps Pharmaceuticals, Inc. New compounds
GB0303503D0 (en) 2003-02-14 2003-03-19 Novartis Ag Organic compounds
PL2910551T3 (pl) * 2003-04-11 2017-09-29 Ptc Therapeutics, Inc. Związki kwasu 1,2,4-oksadiazolobenzoesowego i ich zastosowanie do supresji mutacji nonsensownych i leczenia choroby
US20050075375A1 (en) * 2003-05-14 2005-04-07 Anadys Pharmaceuticals, Inc. Heterocyclic compounds for treating hepatitis C virus
PT2402002T (pt) * 2005-04-08 2018-10-08 Ptc Therapeutics Inc Composições de 1,2,4-oxadiazole oralmente activo para terapia de supressão de mutações nonsense
WO2008030570A1 (en) * 2006-09-08 2008-03-13 Ptc Therapeutics, Inc. Processes for the preparation of 1,2,4-oxadiazole benzoic acids

Also Published As

Publication number Publication date
PL2059513T3 (pl) 2013-06-28
WO2008030570A1 (en) 2008-03-13
UA99265C2 (ru) 2012-08-10
TWI482761B (zh) 2015-05-01
DK2059513T3 (da) 2013-05-06
ZA200901782B (en) 2010-06-30
AR062715A1 (es) 2008-11-26
CA2662749A1 (en) 2008-03-13
US8367841B2 (en) 2013-02-05
JP2010502715A (ja) 2010-01-28
CA2842625C (en) 2016-07-12
RU2495030C2 (ru) 2013-10-10
AR118922A2 (es) 2021-11-10
EP2059513B1 (en) 2013-01-23
EP2059513A1 (en) 2009-05-20
PT2059513E (pt) 2013-04-30
BRPI0716996A2 (pt) 2013-10-08
CA2842625A1 (en) 2008-03-13
IL197445A (en) 2014-01-30
AU2007292915A1 (en) 2008-03-13
TW200823180A (en) 2008-06-01
PE20080771A1 (es) 2008-06-13
ES2404348T3 (es) 2013-05-27
AU2007292915B2 (en) 2012-07-26
AR107474A2 (es) 2018-05-02
BRPI0716996B1 (pt) 2021-02-09
US20080139818A1 (en) 2008-06-12
JP5955494B2 (ja) 2016-07-20
CL2007002606A1 (es) 2008-04-18
MY148598A (en) 2013-05-15
US7678922B2 (en) 2010-03-16
CN101535284A (zh) 2009-09-16
US20100063297A1 (en) 2010-03-11
KR101466368B1 (ko) 2014-11-27
MX2009002439A (es) 2009-03-27
HK1134094A1 (en) 2010-04-16
NZ575511A (en) 2012-02-24
RU2009113019A (ru) 2010-10-20
CA2662749C (en) 2015-01-20
PE20120669A1 (es) 2012-06-01
JP2014193896A (ja) 2014-10-09
CN101535284B (zh) 2014-12-10
BRPI0716996B8 (pt) 2021-05-25
KR20090054464A (ko) 2009-05-29
IL197445A0 (en) 2009-12-24

Similar Documents

Publication Publication Date Title
NZ598012A (en) Processes for the preparation of 1,2,4-oxadiazole benzoic acids
NZ600119A (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
IL196894A0 (en) Process for preparing 3-dihalomethylpyrazole-4-carboxylic acid derivatives
WO2012099734A3 (en) Improved process for preparation of low molecular weight molybdenum succinimide complexes
EG25480A (en) Method for preparation of optionally 2-substituted1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids
WO2009095933A3 (en) Improved and novel process for the preparation of bosentan
WO2010116140A8 (en) New process for preparing hydroxylamines and medicaments
WO2012099736A3 (en) Improved process for preparation of high molecular weight molybdenum succinimide complexes
WO2011077140A3 (en) Method of producing acrylic and methacrylic acid
BR112012007554A2 (pt) método para a fabricação de ácidos amino hidróxi disfofônico
WO2009066735A1 (ja) ２－アザアダマンタン類の製造方法
MX2011011849A (es) Proceso para la preparacion de un compuesto util como inhibidor de tafia.
MX2010009926A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
IL198965A0 (en) Process for preparation of abacavir
NZ597550A (en) Process for the preparation of o-desmethyl venlafaxine and intermediate for use therein
BRPI0507422A (pt) processo para produção de ácido 2,5-dimetilfenilacético
WO2009093258A3 (en) A new and improved process for the preparation of ibandronate sodium monohydrate
NZ598278A (en) Process for preparing biphenyl imidazole compounds
WO2007049295A3 (en) An improved one pot process for making key intermediate for gemcitabine hcl
UA93860C2 (ru) Способ получения пиразолов, способ региоселективного алкилирования и применение фосфата или фосфоната b способе
WO2009072139A8 (en) Process for producing 2-[1-methyl-5-(4-methylbenzoyl)- pyrrol-2- yl]acetic acid or salt thereof
MA32698B1 (fr) Procede de preparation du 1,6:2,3-dianhydro-beta-d-mannopyranose
WO2010086700A3 (en) An improved process for the preparation of choline salt of fenofibric acid and its novel polymorph
MX2009001508A (es) Un proceso novedoso para preparar ester de acido 3-amino-5-fluoro-4-dialcoxipentanoico.
NO20064580L (no) Fremgangsmate for fremstilling av cefalosporinintermediater ved anvendelse av alfa-jodo-1-azetidin eddiksyreestere og trialkylfosfitter

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 06 SEP 2014 BY HENRY HUGHES

Effective date: 20140213

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 06 SEP 2017 BY CPA GLOBAL

Effective date: 20140725

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 SEP 2018 BY JAMES + WELLS

Effective date: 20170823

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 SEP 2019 BY JAMES + WELLS

Effective date: 20180820

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 SEP 2020 BY JAMES + WELLS

Effective date: 20190903

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 SEP 2021 BY IPAN GMBH

Effective date: 20200820

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 SEP 2022 BY ANAQUA SERVICES

Effective date: 20210819

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 SEP 2023 BY ANAQUA SERVICES

Effective date: 20220819

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 SEP 2024 BY ANAQUA SERVICES

Effective date: 20230823

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 SEP 2025 BY ANAQUA SERVICES

Effective date: 20240820

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 SEP 2026 BY ANAQUA SERVICES

Effective date: 20250820